Key result
Loss of myeloid-KLF2 in a murine model was associated with decreased survival and increased proinflammatory cytokine levels after endotoxemia in postnatal day 4 pups compared to day 12 pups.
Why the study?
Preterm neonates die at higher rates from sepsis due to dysregulated immune responses and cytokine storms, and sepsis downregulates KLF2, a tonic repressor of myeloid activation.
Targeting KLF2 or inhibiting the NLRP3 inflammasome may represent a novel strategy to reduce cytokine storm and improve survival in neonatal sepsis.
Hypothesis-generating for KLF2/NLRP3 targeting in neonatal sepsis; prospective human studies needed before clinical adoption.
Preterm neonates die at a significantly higher rate from sepsis than full-term neonates, attributable to their dysregulated immune response. In addition to tissue destruction caused directly by bacterial invasion, an overwhelming cytokine response by the immune cells to bacterial antigens also results in collateral damage. Sepsis leads to decreased gene expression of a critical transcription factor, Krüppel-like factor-2 (KLF2), a tonic repressor of myeloid cell activation. Using a murine model of myeloid-Klf2 deletion, we show that loss of KLF2 is associated with decreased survival after endotoxemia in a developmentally dependent manner, with increased mortality at postnatal day 4 (P4) compared to P12 pups. This survival is significantly increased by neutrophil depletion. P4 knockout pups have increased proinflammatory cytokine levels after endotoxemia compared to P4 controls or P12 pups, with significantly increased levels of IL-1β, a product of the activation of the NLRP3 inflammasome complex. Loss of myeloid-KLF2 at an earlier postnatal age leads to a greater increase in NLRP3 priming and activation and greater IL-1β release by BMNs. Inhibition of NLRP3 inflammasome activation by MCC950 significantly increased survival after endotoxemia in P4 pups. Transcriptomic analysis of bone marrow neutrophils showed that loss of myeloid-KLF2 is associated with gene enrichment of proinflammatory pathways in a developmentally dependent manner. These data suggest that targeting KLF2 could be a novel strategy to decrease the proinflammatory cytokine storm in neonatal sepsis and improve survival in neonates with sepsis.
No takes yet. Share an insight, caveat, or question.
Mukherjee et al. (2025) studied Endotoxemia / neonatal sepsis. Myeloid-Klf2 deletion vs. Controls was evaluated on Survival after endotoxemia. Loss of myeloid-KLF2 in a murine model was associated with decreased survival and increased proinflammatory cytokine levels after endotoxemia in postnatal day 4 pups compared to day 12 pups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: